Clinical Trials
13 trialsNCT06650839 2026-01-07
POC for the Treatment of Subjects With Moderate AS Using Valvosoft® Non-Invasive Ultrasound Therapy
Cardiawave SA
Phase NA Withdrawn
NCT07060183 2025-07-11
Aortic Valve Replacement for Moderate Aortic Stenosis With Left Ventricular Decompensation Early Feasibility Study
Dermed Diagnostics, Inc.
Phase NA Withdrawn
NCT05106192 2025-06-12
Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System.
Case Comprehensive Cancer Center
Phase NA Withdrawn
NCT03956706 2023-03-15
Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas
Northwell Health
Phase NA Withdrawn
NCT04942184 2022-11-01
STRATEGIES to Improve Memory in Alzheimer's Disease
Boston University
Phase NA Withdrawn
NCT02458482 2020-11-13
Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children
Vanderbilt University Medical Center
Phase NA Withdrawn
NCT04503538 2020-10-23
Telemedicine for Early Detection of Cytokine Release Syndrome and Neurotoxicity
Wake Forest University Health Sciences
Phase NA Withdrawn
NCT00093678 2015-10-08
Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer
Eastern Cooperative Oncology Group
Phase NA Withdrawn
NCT01769911 2015-05-07
Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma
Fred Hutchinson Cancer Center
Phase NA Withdrawn
NCT00499668 2013-04-02
Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer
Vanderbilt-Ingram Cancer Center
Phase NA Withdrawn
NCT01558778 2012-07-09
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Phase NA Withdrawn
NCT00378781 2012-02-24
Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection
M.D. Anderson Cancer Center
Phase NA Withdrawn
NCT00110006 2010-06-11
Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma
Case Comprehensive Cancer Center
Phase NA Withdrawn